Recent Press Releases

Access Pharmaceuticals Appoints Industry Executive Anthony Mottola as Vice President of Managed Care and Market Access

Mottola To Join Investor Update Conference Call Today At 11:00 am EDTDALLAS and NEW YORK, March 23, 2011 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTC Bulletin Board: ACCP), a biopharmaceutical

A Life Sciences Renaissance: 125th Peer-Reviewed Publication Enabled By xCELLigence System

PENZBERG, Germany--(BUSINESS WIRE)-- To date, more than 125 peer-reviewed studies using Roche’s (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY) xCELLigence System have been published, spanning a diverse group

ITG's Majestic Market Research Prostate Cancer Study Indicates Amgen's Xgeva is Poised to Steal Significant Share From Novartis'

NEW YORK, March 22, 2011 /PRNewswire/ -- A study in the prostate cancer space completed this week by ITG's Majestic Market Research reveals that Amgen's (Nasdaq: AMGN) Xgeva (a.k.a. denosumab,

BlueLibris to Launch New Mobile Monitoring Devices on AT&T Network

Pilot of New Consumer Device and Services to Commence in the Middle of the YearDALLAS, March 22, 2011 /PRNewswire/ -- AT&T* today announced an agreement with BlueLibris to provide wireless

Diabetes Prevention and Control Alliance Programs Expand to Atlanta to Help Tackle City’s Diabetes Crisis

Atlanta among first cities in the nation to have access to community-based programs from UnitedHealth Group, Walgreens and the Y proven to prevent and control diabetesDelta Air Lines among the first

Merck and sanofi-aventis to maintain separate businesses in animal health

Merck and sanofi-aventis to maintain separate businesses in animal health Mar 22, 2011 Whitehouse Station, NJ and Paris, France - March 22, 2011 - Merck (NYSE: MRK) and sanofi-aventis (EURONEXT: SAN

Seattle Genetics Announces Antibody-Drug Conjugate Collaboration with Abbott

Seattle Genetics to receive $8 million upfront payment, plus potential milestone payments and royalties under single-target collaboration BOTHELL, Wash.--(BUSINESS WIRE)-- Seattle Genetics, Inc.

Lilly Announces Important Action Regarding Recall of Alcohol Prep Pads Made by Triad Group Included in Forteo Starter Kits

Lilly Announces Important Action Regarding Recall of Alcohol Prep Pads Made by Triad Group Included in Forteo Starter Kits INDIANAPOLIS, March 17, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE:

Cellular Dynamics International and Roche Transition Early Access Collaboration into a Standard Supply Agreement Ahead of Schedu

MADISON, Wis., March 22, 2011 /PRNewswire/ -- Cellular Dynamics International (CDI) announced today that their two-year collaboration with Roche (SIX: RO, ROG; OTCQX: RHHBY) to substantiate CDI's

FDA, EMA announce pilot for parallel assessment of Quality by Design applications

FDA, EMA announce pilot for parallel assessment of Quality by Design applications FDA NEWS RELEASEFor Immediate Release: March 16, 2011Media Inquiries: Morgan Liscinsky, 301-796-0397,

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 March

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 March 18/03/2011 Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 14-17 March

Quality standards for widely used medicines strengthened

Quality standards for widely used medicines strengthened Contact: Laura Provanlnp@usp.org301-816-8268US Pharmacopeia USP teaming with FDA and CHPA to apply modern test methods to acetaminophen,

Merck and sanofi-aventis to Maintain Separate Businesses in Animal Health

WHITEHOUSE STATION, N.J. & PARIS--(BUSINESS WIRE)-- Merck (NYSE: MRK) and sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced today the mutual termination of their agreement to form a new

National Nasal Allergy Survey Reveals Unmet Needs Still Exist Among Patients Living With Allergic Rhinitis

-- Teva Respiratory Presents Key Findings at American Academy of Allergy Asthma & Immunology Annual Meeting --SAN FRANCISCO, March 21, 2011 /PRNewswire/ -- Results from a recent pivotal allergic

Watson Launches Generic Famvir®

MORRISTOWN, N.J., March 21, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc. has launched Famciclovir tablets, 125 mg, 250

Cordis Demonstrates Commitment to Advancing Therapies for Below-the-Knee Vascular Disease

Launches SLEEK® OTW Catheter, a new .014 Over-the-Wire PTA Catheter BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Cordis Corporation is pleased to announce the launch of SLEEK® OTW Catheter, a new .014”

Phase III Study of Investigational Compound Ipilimumab Achieves Primary Endpoint of Improvement in Overall Survival in

PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) today announced that a clinical trial -- known as study 024 -- of its investigational compound ipilimumab has met the

NACDS Comments on Newly-Released Report on Pharmaceutical Supply Chain Integrity

Alexandria, Va. - The National Association of Chain Drug Stores (NACDS) today commented on a report prepared by the Office of Intellectual Property Enforcement Coordinator (IPEC), the Food and Drug

PhRMA Commends the Administration for Increased Attention To Worldwide Counterfeit Medicine Threat

Washington, D.C. (March 11, 2011) - Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani today issued the following statement: "PhRMA supports and

SOCMA's BPTF and CEFIC's EFCG Work with FDA to Protect Public Safety

SOCMA's BPTF and CEFIC's EFCG Work with FDA to Protect Public Safety March 8, 2011 Media Contact:Christine SanchezManager, Public Relations & Media(202) 721-4182sanchezc@socma.com Washington, DC